s6y

4 Somaxon Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001209191-12-034920

Documents

  1. FORM 4 SUBMISSION 4
  2. FORM 4 SUBMISSION 4

On sec.gov